I've been managing purchasing for a surgical center since 2021. Roughly $1.8M a year in medical supplies across 15 vendors, reporting to both operations and finance. It sits between what clinicians want and what the budget allows, and neither side thinks you're doing enough.
In early 2023, I thought I'd found a rare win. Our endoscopy team used about 180 biopsy forceps per quarter. Our established vendor charged $72 per unit. A newer supplier offered what looked like the same tool at $43 — same jaw size, same working length, claimed compatibility with our scope systems. Over $20,000 in projected annual savings. I was proud of that number.
Within three months, that decision had cost us roughly $14,000. Here's what happened.
Why Buying Medical Devices Like Office Supplies Fails
The trap I fell into is the classic procurement mistake: treating medical devices as interchangeable commodities. When I buy printer paper or exam table covers, unit price is almost all that matters. But a biopsy forceps is not printer paper. Two devices can share the same spec sheet and behave completely differently inside an endoscope channel. Those differences show up in procedure time, failure rate, training needs, and service response.
None of those variables appear on a purchase order. The vendor quoting $43 doesn't list "estimated failure rate per 100 procedures" on their quote. They don't tell you their training program is a link to a video. They don't tell you what happens when something goes wrong on a Friday afternoon.
Per the FTC's advertising guidance (ftc.gov), vendors have to substantiate claims about their products. I want to be fair here: the $43 supplier wasn't lying. "Same jaw size" and "same working length" were true statements. But true statements aren't the same as useful information. The question I should have asked — what does this device cost us across a full year of use? — was never going to be answered by a spec sheet.
I do not blame procurement teams for falling into this trap. Most of us are evaluated on unit cost. The buyer who negotiates $43 per forceps gets praised at budget review. The buyer who argues "I'm paying $72 because the pricier device saves OR time" has to defend that with data. And the data doesn't exist until you've already made the mistake and measured the damage.
The "cheapest device per unit" thinking comes from an era when procurement focused on categories with minimal performance differences. That era ended. Devices are more sophisticated, procedures are more complex, and the cost of a failed case is far higher than any per-unit saving. The thinking hasn't caught up.
What the "Cheaper" Forceps Actually Cost Us
We switched to the $43 forceps in March 2023. The first month looked fine. Then the GI lab manager pulled me aside with a pattern: the jaw mechanism was less predictable when the physician took a second bite. In about 15 procedures — maybe a dozen, I'd have to check the quality log — out of roughly 180 over two months, the endoscopist had to withdraw the scope, discard the forceps, and go back in with a second unit.
Here's the math that got my attention:
- Extra OR time. 15 failed passes × roughly 15 extra minutes each = 225 minutes. At our internal estimate of $40 per minute, that's $9,000.
- Rescheduled procedures. Two of those cases ran long enough that the next patient's procedure was pushed to another day. Each OR slot is worth about $2,500 in utilization — another $5,000.
- Wasted devices. The failed forceps plus the replacement used on each pass added a few hundred dollars more.
Total: just north of $14,000 in two months, against the $5,220 per quarter I thought I was saving. The savings disappeared and then some.
The frustrating part? My gut had flagged it. On the evaluation call, the sales rep said "the specs are the same, just try it." No clinical specialist offered to set up a trial. When I asked about training, I got a video link. Every spreadsheet analysis said $43, but something felt off. I dismissed it as supplier bias — I'd been trained to trust data over vibes. Turns out the data was just incomplete.
When the failures started, we called the supplier. We got a ticketing system. A promise to "look into it." Nobody visited. Nobody offered to train our physicians. We eventually went back to our original vendor, ate the return shipping, and absorbed the switching cost. The savings we chased evaporated completely.
How I Buy Medical Devices Now
I rebuilt my procurement process around total cost of ownership. Before any significant purchase, I model four things: unit price including shipping, procedure-time impact, expected failure rate, and the quality of training and service support. A fifth consideration — vendor consolidation — comes into play when a single supplier can serve multiple departments cleanly.
It's more work upfront. It has also stopped me from repeating the $43 forceps mistake in about four other categories since then.
This is my honest answer to a question colleagues ask: why use Boston Scientific cardiovascular products? It's not because their prices are always the lowest — they're often not. It's because they win on total cost. Their stents, balloons, and delivery catheters have performed reliably in our cath lab, and their field support shows up: clinical specialists for training days, not just an email address. Endoscopy Boston Scientific products have held up well in our repair cycle. And in urology, where you're choosing among types of incontinence products — intermittent catheters, indwelling catheters, external collection systems, absorbent products — the TCO lens matters because unit price alone will mislead you.
Does Boston Scientific win every comparison? No. For categories outside their portfolio — orthopedic implant purchasing, hospital bed upgrades, capital equipment — the same TCO framework applies with other vendors. The framework is the point.
The Bottom Line
I'm not saying the cheapest quote is always wrong. Sometimes it's a legitimate value. But it's never a substitute for asking harder questions.
The spreadsheet wasn't lying. It was incomplete. Next time a vendor says "the specs are the same, just try it," ask about failure rates, procedure time, training, and support. If they can't answer, you already have your answer.